Inventor
Jeffrey S. Nissen
Inventor
Indianapolis, IN, US
Overview
Patents· 51 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes34%
C07DHeterocyclic compounds20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07CAcyclic or carbocyclic compounds12%
C07KPeptides11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
7,790,744'Cyclic peptide antifungal agents and process for preparation thereof'20107,468,365'Lactam compound'20087,153,847'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds'20066,951,854'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds'20056,916,784'Cyclic peptide antifungal agents and process for preparation thereof'20056,888,022'Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis'20056,861,558'Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis'20056,849,650'Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds'20056,767,918'N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20046,743,777'Cyclic peptide antifungal agents and process for preparation thereof'20046,683,075'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use'20046,667,305'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,653,303'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,642,261'N-(aryl/heteroarylacety) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,635,632'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,632,811'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,579,867'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,559,141'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,544,978'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,541,466'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,506,782'Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,495,693'N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20026,486,350'Biological reagents and methods for determining the mechanism in the generation of -amyloid peptide'20026,479,517'Phosphorous-containing benzothiophenes'20026,476,263'Compounds for inhibiting -amyloid peptide release and/or its synthesis'20026,399,628'N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting alpha- amyloid peptide release and/or its synthesis by use of such compounds'20026,384,013'Cyclic peptide antifungal agents and process for preparation thereof'20026,333,351'N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'20016,313,152'N(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'20016,262,302'N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'20016,211,235'Compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis'20016,207,710'Compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis'20016,191,166'Methods and compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis'20016,172,073'Compounds having effects on serotonin-related systems'20016,153,652'N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'20006,117,901'N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use'20006,107,307'Inhibition of serotonin reuptake'20006,096,782'N-(aryl/heteroaryl) amino acid derivatives pharmaceutical compositions comprising same and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'20006,046,215'Inhibition of serotonin reuptake'20005,998,443'Phosphorous containing benzothiophenes for treating estrogen deficiency'19995,965,614'N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'19995,965,525'Cyclic peptide antifungal agents'19995,962,474'5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1h-indoles: 5-HT.sub.1F agonists'19995,932,543'Cyclic peptide antifungal agents and process for preparation thereof'19995,846,982'Inhibition of serotonin reuptake'19985,789,402'Compounds having effects on serotonin-related systems'19985,721,252'5HT.sub.1F agonists for the treatment of migraine'19985,708,008'5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1H-indoles: new 5-HT.sub.1F agonists'19985,631,265'8-substituted tetrahydro-beta-carbolines'19975,627,196'Compounds having effects on serotonin-related systems'19975,521,196'5-HT.sub.1F agonists for the treatment of migraine'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2010Patents assigned to LILLY CO ELI (50)· patent assignee history
1996–2010Based in Indianapolis, IN, US· patent location history
1997–2002Based in Fishers, IN, US· patent location history
1999–2005Patents assigned to ATHENA NEUROSCIENCES INC (20)· patent assignee history
2000–2005Patents assigned to ELAN PHARM INC (8)· patent assignee history
2008Patents assigned to ELAN (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LILLY CO ELI | 50 | 1996–2010 |
| ATHENA NEUROSCIENCES INC | 20 | 1999–2005 |
| ELAN PHARM INC | 8 | 2000–2005 |
| ELAN | 1 | 2008 |
Locations
| Location | Patents | Span |
|---|---|---|
| Indianapolis, IN, US | 46 | 1996–2010 |
| Fishers, IN, US | 5 | 1997–2002 |